| Dr Robert Blake Tandy, DDS, MS | |
|
1236 Vista Verde Rd, Ukiah, CA 95482-7553 | |
| (707) 972-1123 | |
| (707) 468-0899 |
| Full Name | Dr Robert Blake Tandy |
|---|---|
| Gender | Male |
| Speciality | Dentist - Periodontics |
| Location | 1236 Vista Verde Rd, Ukiah, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043232499 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0300X | Dentist - Periodontics | 20052 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Blake Tandy, DDS, MS 1236 Vista Verde Rd, Ukiah, CA 95482-7553 Ph: (707) 972-1123 | Dr Robert Blake Tandy, DDS, MS 1236 Vista Verde Rd, Ukiah, CA 95482-7553 Ph: (707) 972-1123 |
News Archive
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.
Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.
Offering smokers a taster session at an NHS Stop Smoking Service and explaining their personal risk of developing smoking-related diseases doubles their likelihood of attending a stop smoking course, according to a study in The Lancet.
Axovant Sciences Ltd., a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced the first patients screened in MINDSET, a confirmatory global phase 3 study of Axovant's lead product candidate, RVT-101. Axovant also announced that the company and the U.S. Food and Drug Administration have agreed to a Special Protocol Assessment (SPA) supporting this phase 3 program.
› Verified 7 days ago
Andrew Irvine Corbett, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 135 Hospital Dr, Ukiah, CA 95482 Phone: 707-462-6086 | |
Kenneth Barry, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1252 Airport Park Blvd, Suite D1, Ukiah, CA 95482 Phone: 707-462-8719 | |
Dr. Anthoula S Vlachos, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 471 Lovers Ln, Ukiah, CA 95482 Phone: 707-972-2602 | |
Dr. Nicholas Nadiem Khoury, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 415 W Standley St, Ukiah, CA 95482 Phone: 707-462-2170 Fax: 707-462-1953 | |
Dr. Gary R Keszler, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 135 Hospital Dr, Ukiah, CA 95482 Phone: 707-462-6086 | |
Dr. William Green, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 772 S Dora St, Ukiah, CA 95482 Phone: 707-462-2913 Fax: 707-462-0350 |